Exclusive

Publication

Byline

Location

Equity mutual fund inflows dip in February, debt funds see outflows: AMFI Data

Mumbai, March 12 -- Equity mutual funds experienced a slowdown in net inflows during February 2025, according to data released by the Association of Mutual Funds in India (AMFI). Net inflows for equit... Read More


Board of TajGVK Hotels & Resorts appoints director

Mumbai, March 12 -- The Board of TajGVK Hotels & Resorts at its meeting held on 12 March 2025 has approved the appointment of G Indira Krishna Reddy (DIN: 00005230) as Non Executive & Non Independent ... Read More


Board of Power Finance Corporation recommends Fourth Interim Dividend

Mumbai, March 12 -- Power Finance Corporation announced that the Board of Directors of the Company at its meeting held on 12 March 2025, has recommended a Fourth Interim dividend of Rs.3.50 per share ... Read More


Acuit Ratings upgrades ratings of Andrew Yule & Co. to 'B' with 'stable' outlook

Mumbai, March 12 -- The agency has reaffirmed the short-term rating of 'ACUITE A4' on the Rs. 38.10 crore bank facilities of AYCL. The rating upgrade and transition from 'Issuer non-cooperating' refl... Read More


Indices trim some losses; European mkt advance

Mumbai, March 12 -- The domestic indices pared some losses but remained in negative territory with limited losses in afternoon trade. The Nifty traded above the 22,400 level after hitting day's low of... Read More


IDFC First Bank Ltd eases for fifth straight session

Mumbai, March 12 -- IDFC First Bank Ltd dropped for a fifth straight session today. The stock is quoting at Rs 54.67, down 1.25% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down arou... Read More


Zydus Life gets US FDA nod for UTI treatment drug Methenamine

Mumbai, March 12 -- The approved ANDA is a generic version of the US reference listed drug (USRLD) Hiprex Tablets. Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatmen... Read More


Glenmark Pharmaceuticals launches Empagliflozin in India

Mumbai, March 12 -- Glenmark Pharmaceuticals has launched Empagliflozin, a widely recognized SGLT2 inhibitor, in India. The drug has been introduced under the brand name Glempa (Empagliflozin 10/25 mg... Read More


Board of Affle (India) appoints director

Mumbai, March 12 -- The Board of Affle India has recommended the appointment of Dr. Hanny Kusnadi (DIN:10996871) in the capacity of Independent Director for a term of two (2) years with effect from 08... Read More


Adani Energy Solutions receives ratings action from Fitch Ratings

Mumbai, March 12 -- Adani Energy Solutions has received the following ratings action from Fitch Ratings: Published by HT Digital Content Services with permission from Capital Market.... Read More